Increasing Incidence Rate of Cataract to Augment the Ophthalmic Femtosecond Lasers Market Growth
Femtosecond laser is an infrared, ultrafast, ultrashort pulse laser with a wavelength of 1053 nm.
Femtosecond lasers produce photoionization/photodisruption of the optically transparent tissue such
as cornea. These layers have a wide range of applications in ophthalmic surgery. Ophthalmic
femtosecond lasers are used to correct myopia (a common vision condition). The procedure
involves making two lamellar cuts in the cornea that intersect in the periphery, thus creating a
lenticule that is removed. Moreover, ophthalmic femtosecond laser allows doctor to select the flap
thickness and flap diameter, as well as cutting angle, diameter, and position of the hinge.
Increasing incidence rate of cataract and growing geriatric population worldwide is expected to
propel the growth of the ophthalmic femtosecond lasers market. The leading causes of vision
impairment and blindness are refractive errors and cataracts. For instance, worldwide, at least 1
billion people have a near or distance vision impairment that could have been prevented or has yet
to be addressed, according to the World Health Organization (WHO).
Moreover, increasing prevalence of ophthalmic disorders, increasing regulatory approvals for
ophthalmic lasers, and technological advancements are expected to aid in the growth of the
ophthalmic femtosecond lasers market. For instance, in March 2018, Alcon received 510(k)
clearance from the U.S. FDA (Food and Drug Administration) for LenSx Laser (a femtosecond
laser) for the indication of intracorneal rings and pockets for presbyopia-correcting inlays.
Increasing prevalence of chronic diseases such as diabetes, especially in North America, and
initiatives to control visual impairment are also expected to fuel the growth of the ophthalmic
femtosecond lasers market. For instance, according to American Diabetes Association, in 2018,
around 34.2 million Americans, or 10.5% of the popula